Incidence rate for study outcomes.

<div><p>Background</p><p>With the increasing survival rate and overall lifespan of patients with breast cancer, increased mortality due to cardiovascular causes is a notable concern. Anthracyclines, which are commonly used and effective chemotherapeutic agents for breast canc...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Yu-Cheol Lim (9859320) (author)
مؤلفون آخرون:	Yoon Jae Lee (7294811) (author), In-Hyuk Ha (587172) (author), Ye-Seul Lee (692714) (author)
منشور في:	2025
الموضوعات:	Medicine Cell Biology Biotechnology Developmental Biology Cancer Science Policy Infectious Diseases initial anticancer treatment increasing survival rate existing studies vary effective chemotherapeutic agents 892 &# 8211 882 &# 8211 823 &# 8211 443 ]), although 093 &# 8211 coronary artery disease composite cardiovascular event increased mortality due congestive heart failure composite cardiovascular events adjusted hr 0 incidence rate ratios individual risk factors adjusted hr 1 adjuvant anthracycline therapy heart failure cardiovascular events cardiovascular disease increased risk hazard ratios ci 0 cause mortality based therapy adjuvant trastuzumab cardiovascular causes risk factors heterogeneous factors xlink "> thorough monitoring subgroup analysis study population study compared significantly associated significant association quality evidence overall lifespan notable concern nationwide cohort irr ), incidence rates hypertensive comorbidities findings owing derived using comprehensively examine comorbid hypertension commonly used
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Incidence rate for study outcomes.

مواد مشابهة